Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of TRPM8 Agonist on Tear-lipid Thickness
NCT07888452Phase 4Not yet recruiting
- Sponsor
- University of California, Berkeley
- Start
- Nov 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 4 trial of acoltremon in dry eye syndrome (DED), sponsored by University of California, Berkeley. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
acoltremon
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT07888452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07888452.